GBM IDH-wt 71.4% (5/7)GBM IDH-mut 100% (4/4)DMG 80% (4/5)AA 50% (1/2)DA 0% (0/1)AO 100% (8/8)OD 0% (0/1)Other glioma 100% (6/6). This evidence concerns the gene IDH2 and central nervous system cancer.